An official website of the United States government
Government Funding Lapse Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Trial Status: active
The purpose of this study is to find out whether the study drug, LY4170156, is safe,
tolerable and effective in participants with advanced solid tumors. The study is
conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib
(dose-expansion). The study will last up to approximately 4 years.
Inclusion Criteria
Have one of the following solid tumor cancers:
Dose Escalation: Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer, endometrial cancer, cervical cancer, non-small cell lung cancer (NSCLC), triple negative breast cancer (TNBC), pancreatic cancer, or colorectal cancer (CRC)
Dose Optimization: Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) and endometrial cancer
